It has been 22 years since the Food and Drug Administration approved a new prescription drug treatment for head lice, but now several new remedies are on the horizon.
What's in the future
More information on lice and the misconceptions surrounding them can be found under Web Exclusives on http://www.drugtopics.com.
THE AUTHOR is a writer based in New Hampshire.
FDA Issues CRL for Heplisav-B in Adults With ESRD on Hemodialyis
May 14th 2024Dynavax plans to meet with the FDA to discuss how the company can provide additional data to support the approval of its 4-dose Heplisav-B regimen and expand protection for adults with end-stage renal disease (ESRD) on hemodialysis.